Table 1: Clinical and laboratory features of 120 patients with primary biliary cirrhosis (PBC) participated in the study.

FeaturePBC ( )

Age (median; range)56 (22–83)
Gender (M/F)11/109
AMA (pos/neg)101/19
Anti-sp100 (pos/neg)27/92
Anti-gp210 (pos/neg)15/104
Cirrhosis (yes/no) (%)33/85 (28/72%)
ALT (median; range) IU/L (Normal: 3–30)90 (10–987)
ALP (median; range ), IU/L (Normal: 40–120)304 (47–2264)
GGT (median; range), IU/L (Normal: 3–30)311 (11–2608)
Bilirubin (median; range), mg/dL (Normal: 0.2–1.0)1.9 (0.2–25.1)
Albumin (median; range), g/dL (Normal: 3.8–4.4)3.9 (2.3–5.8)
INR (median; range) (Normal: 0.8–1.2)1.04 (0.8–2.3)
Cholesterol (median; range ), mg/dL ( )249 (108–1096)
Triglycerides (median; range), mg/dL ( )124 (42–448)

In 1 patient these tests were not done; in 2 patients fibrosis status was not determined.
M: male; F: female; AMA: antimitochondrial antibody; Pos: positive; Neg: negative.